Worldwide: IP Think Tank Global Week In Review

Last Updated: 5 December 2007
Article by Duncan Bucknell

Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet.

Highlights this week included: copyright & trademark trolls, the constitutional challenge to Brazil's IP law, Norway & Croatia join the EPC, the EPO's financial crisis, France's new rules on liability of ISPs, Amazon's one click patent lives on (in amended form), and TiV's patent claims survive re-exam intact.

Please join the discussion by adding your comments on any of these stories, and please do let me know if you think we’ve missed something important, or if there is a source you think should be monitored.

You can separately subscribe to the IP Thinktank Global week in Review at


  • Medicine 2.0: Online peer review? Facebook for physicians?: (MaRS),
    • ISPs fear trend towards greater liability for content: (IPWatch),
    • Customers lose faith in phished brands: (ArsTechnica)
    • Settling IP Litigation, Indian patent transparency, national differences, Friction & Warfighting: (StrategicIP),
    • WIPO hosts international round table on the economics of IP: (WIPO)
    • Bringing liquidity to the IP Marketplace: It’s the information, stupid!: (Michael Pierantozzi),
    • Convergence brings bad news for IP owners: (IAM),
    • DMCA-Style laws going to Canada, Switzerland and the world: (ArsTechnica),
    • Comcast puts non-lawyer in charge of IP Strategy: (IAM),
    • Are green technology IP rights owners about to become the new big pharma?: (IAM),
    • Latest WIPO SME newsletter: (WIPO),


  • Roche extends patent fight (to include Abbott) over diabetes test strips: (IPLaw360),
    • WHO funded study reveals 3.1% of drugs sold in India are counterfeit suspects: (SpicyIP),
    • Another piece on the impressive R&D programs of India's (generic?) pharmaceutical companies: (SpicyIP),
    • Adenoscan (Adenosine) - Astellas Pharma, King Pharmaceuticals, and Teva Settle Adenoscan® Patent Suit: (PatentDocs),
    • Clarinex (Desloratadine) - Schering Corp. adds Anchen Pharmaceuticals Inc. to the long list of companies sued for patent infringement: (IPLaw360),
    • Cosopt (dorzolamide hydrochloride and timolol maleate) - Merck achieves dismissal of invalidity claims & thwarts Apotex's chance at 180 d exlusivity: (OrangeBookBlog),
    • Depakote (Valproate semisodium) - Abbott sues proposed generic: (IPLaw360),
    • Iressa (Gefitinib) - rejected under India's new patent laws: (SpicyIP),
    • Lovenox (Enoxaparin) - patent infringement litigation between Aventis and Teva/Amphastar is making its second trip to the Federal Circuit: (OrangeBookBlog),
    • Omacor (Omega-3 fatty acid) - German court invalidates Pronova BioPharma patent: (IPLaw360),


  • Summary Judgment in counterfeit dishwashing detergent case highlights need to know manufacture: (IPWars),
  • Brazil

  • National Federation of Pharmacists (FENAFAR) argues unconstitutionality of Brazilian IP law: (e-drug),
  • Canada

  • The Canadian Intellectual Property Office has recently added features to the online patent database.: (Now why didn't I think of that),
    • Ontario court ruled that Richard Warman, was defamed online in a series of postings: (Michael Geist),
    • Canada’s Copyright law is Stronger and Better than U.S.’s: (Michael Geist),


  • Danone-Wahaha Dispute: No End in Sight: (China Business Law Blog), (China Law Blog),
    • Link Between Counterfeiting and Organised Crime: (IPDragon),
    • Preferring Price Discrimination Over Sidestepping Patents?: (IPDragon),
    • China Bad News For Thailand's Counterfeit Manufacturers: (IPDragon),
    • Consortium of 5 Hollywood studios is suing and Eastday Bar in China for copyright infringement in relation to movies in internet cafes: (IPKat),
    • Formation of the WTO panel requested by the US on China’s distribution of copyrighted material was delayed after a procedural move on an unrelated matter: (IPWatch),
    • One-third of European companies in China have no IP problems at all: (IAM),


  • Norway accedes to the European Patent Convention: (EPO), (BLOG@IP::JUR)
    • Croatia accedes to the European Patent Convention: (EPO), (BLOG@IP::JUR),
    • European Union governments on Thursday agreed the main components of a patent litigation system that will apply throughout the 27-country bloc: (IPWatch)
    • Legal Affairs Committee of the European Parliament backs Commission Proposal to end design protection for spare car parts: (IPRHelpdesk), (I/PUpdates),
    • EPO faces deficit crises: (IAM),
    • New anti-trust guidelines for mergers from European Commission: (OUTLAW),
    • EU Parliament urges change in IP rules for environmental technology: (IPWatch),
    • European Commission expected to publish communication on creative content online by year's end: (IPWatch),
    • Criticism and discussion of the European Commission's performance over the EPLA: (IPEG),
    • Nokia makes little progress in its European Qualcomm patent fight: (IPEG),


  • France is about to implement new rules that will require ISPs to monitor their customers' activities and disclose file sharing activity to a new independent body: (Michael Geist), (ArsTechnica), (ZDNet), (OUTLAW), (IPWatch),
  • Germany

  • Germany public TV starts creative commons experiment: (Lessig Blog), (CreativeCommons),
  • India

  • An improving scenario for trademark owners in India: (IAM),
    • Geographical Indication" (GI) Application for "Darjeeling" in Europe: (SpicyIP),
    • Government issues Circular on border enforcement of IPRs: (SpicyIP),
    • YouTube v T-Series - more on this dispute: (SpicyIP)
    • CIPLA Milking Indian Consumers? Charity Does Not Begin at Home!: (SpicyIP),
    • SpicyIP Petition: Indian Patent Database: (SpicyIP),
    • Natco (unsurprisingly) considering challenge to HC ruling on Glivec: (SpicyIP),
    • Music copyright infringement in India: (SpicyIP),
    • Indian centres drive US patent rush: (SpicyIP),
    • When faces are not billboards: (SpicyIP),
    • Educomp - an unusual approach to property development - supply IP Schools: (SpicyIP),
    • Copyright notices to ISPs on the rise: (SpicyIP),


  • Indonesia Mulls Compulsory Licences On Three More HIV/AIDS Drugs: (IPWatch), (Generic Pharmaceuticals & IP),
  • Italy

  • Great discussion of colour trade marks: (Catch Us If You Can!),
  • Israel

  • Israel passed its first Copyright Law: (IPFactor), (Michael Geist),
  • Nigeria

  • One Laptop Per Child Association sued for patent infringement: (Philip Brooks),
  • Taiwan

  • Taiwan's Exciting 2007: IP Case Proceeding, IP Court and Patent Attorney Acts: (IPDragon),
  • Thailand

  • Thai and foreign public health campaigners urged governments to exercise their right over patent owners to provide access to cheaper essential medicines for the poor: (IPWatch),
  • United Kingdom

  • Triumph of style over substance? (UK Channel Management Ltd v E! Entertainment Television Inc and another): (IPKat),
  • United States

  • Amazon one click patent is back after some careful amendments: (IPKat), (OUTLAW), (IPBiz), (Against Monopoly)
    • SPAMARREST mark allowed by TTAB through despite objection based on earlier SPAM mark: (IPKat), (I/PUpdates),
    • Apple and have agreed on a settlement in the Apple v. case, which involves Apple paying a one-time, $10 million licensing fee: (ArsTechnica), (Copyfight), (Patent Prospector),
    • Committee report will give clearer picture of the state of play at the USPTO: (IAM),
    • Supreme Court declined to hear an appeal brought by a California software company against Viacom Inc. involving alleged trademark infringement: (IPLaw360),
    • Injunction deals another blow to Stryker: (IPLaw360),
    • Cordance Faces Claim Over Amazon’s Software Patent: (IPLaw360),
    • Gemini Moves From Madison, Wisconsin to Marshall, Texas, and then Sues 11more: (Patent Troll Tracker),
    • RIAA ordered to divulge its expenses it has incurred for each of the 38 songs cited in a copyright infringement lawsuit: (ArsTechnica),
    • United Health HSA cards accused of patent infringement: (IPLaw360),
    • Saint-Gobain has sued Dow and 5other manufacturers in a suit for allegedly infringing its tubing and connector technology: (IPLaw360),
    • Car companies hit with patent suit by holding company for technology required to meet government regulations: (IPLaw360),
    • LCD has announced a settlement with its Taiwanese rival Chunghwa Picture Tubes over their protracted patent dispute: (IPLaw360),
    • Amazon, Borders settle patent suit over electronic message interpretation systems: (IPLaw360),
    • GraphOn Corp. and Inc. settled their 2 year patent litigation: (IPLaw360),
    • ITC to investigate in Acer v HP patent dispute: (IPLaw360),
    • TiVo patent claims survive re-exam intact; EchoStar doomed?: (IPBiz), (ArsTechnica),
    • CAFC - operability of 102(g) defence (first to conceive then reasonable diligence) - [z4 Technologies v. Microsoft Corp. (Fed. Cir. 2007)]: (Patently'O),
    • Microsoft loses appeal in product activation patent case: (ArsTechnica)

    The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

    To print this article, all you need is to be registered on

    Click to Login as an existing user or Register so you can print this article.

    Some comments from our readers…
    “The articles are extremely timely and highly applicable”
    “I often find critical information not available elsewhere”
    “As in-house counsel, Mondaq’s service is of great value”

    Mondaq Advice Centre (MACs)
    Up-coming Events Search
    Font Size:
    Mondaq on Twitter
    Register for Access and our Free Biweekly Alert for
    This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
    Email Address
    Company Name
    Confirm Password
    Mondaq Topics -- Select your Interests
     Law Performance
     Law Practice
     Media & IT
     Real Estate
     Wealth Mgt
    Asia Pacific
    European Union
    Latin America
    Middle East
    United States
    Worldwide Updates
    Check to state you have read and
    agree to our Terms and Conditions

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    If you do not want us to provide your name and email address you may opt out by clicking here .

    If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.